Hypoxia-mediated control of HIF/ARNT machinery in epidermal keratinocytes

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 1, 2011, Pages 60-72

  Weir, Lynda ^a   Robertson, Douglas ^a   Leigh, Irene M ^a   Vass, J Keith ^a   Panteleyev, Andrey A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

ARNT; HIF1a; HIF3a; Hypoxia; Keratinocyte; Splicing

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANIMAL CELL; ARTICLE; CLINICAL ASSESSMENT; DOWN REGULATION; EPIDERMIS; HUMAN; HUMAN CELL; HYPOXIA; KERATINOCYTE; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ISOLATION; WESTERN BLOTTING;

ALTERNATIVE SPLICING; ANIMALS; ANIMALS, NEWBORN; ANOXIA; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; GENE EXPRESSION PROFILING; HUMANS; KERATINOCYTES; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650276016     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.11.014     Document Type: Article

References (65)

1. Jiang B.H., Rue E., Wang G.L., Roe R., Semenza G.L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 1996, 271:17771-17778.
2. Gruber M., Simon M.C. Hypoxia-inducible factors, hypoxia, and tumor angiogenesis. Curr. Opin. Hematol. 2006, 13:169-174.
3. Huang L.E., Gu J., Schau M., Bunn H.F. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA 1998, 95:7987-7992.
4. Arany Z., Huang L.E., Eckner R., Bhattacharya S., Jiang C., Goldberg M.A., Bunn H.F., Livingston D.M. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl Acad. Sci. USA 1996, 93:12969-12973.
5. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002, 16:1466-1471.
6. Tanimoto K., Makino Y., Pereira T., Poellinger L. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J. 2000, 19:4298-4309.
7. Guillemin K., Krasnow M.A. The hypoxic response: huffing and HIFing. Cell 1997, 89:9-12.
8. Wenger R.H., Rolfs A., Kvietikova I., Spielmann P., Zimmermann D.R., Gassmann M. The mouse gene for hypoxia-inducible factor-1alpha-genomic organization, expression and characterization of an alternative first exon and 5' flanking sequence. Eur. J. Biochem. 1997, 246:155-165.
9. Wenger R.H., Rolfs A., Spielmann P., Zimmermann D.R., Gassmann M. Mouse hypoxia-inducible factor-1alpha is encoded by two different mRNA isoforms: expression from a tissue-specific and a housekeeping-type promoter. Blood 1998, 91:3471-3480.
10. Lukashev D., Caldwell C., Ohta A., Chen P., Sitkovsky M. Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 alpha in activated T lymphocytes. J. Biol. Chem. 2001, 276:48754-48763.
11. Ramanathan M., Luo W., Csoka B., Hasko G., Lukashev D., Sitkovsky M.V., Leibovich S.J. Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adenosine A(2A) receptor agonists. J. Leukoc. Biol. 2009, 86:681-689.
12. Kietzmann T., Cornesse Y., Brechtel K., Modaressi S., Jungermann K. Perivenous expression of the mRNA of the three hypoxia-inducible factor alpha-subunits, HIF1alpha, HIF2alpha and HIF3alpha, in rat liver. Biochem. J. 2001, 354:531-537.
13. Sekine H., Mimura J., Yamamoto M. Unique and overlapping transcriptional roles of arylhydrocarbon receptor nuclear translocator (Arnt) and Arnt2 in xenobiotic and hypoxic responses. J. Biol. Chem. 2006, 281:37507-37516.
14. Carroll V.A., Ashcroft M. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res. 2006, 66:6264-6270.
15. Takeda N., O'Dea E.L., Doedens A., Kim J.W., Weidemann A., Stockmann C., Asagiri M., Simon M.C., Hoffmann A., Johnson R.S. Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis. Genes Dev. 2010, 24:491-501.
16. Makino Y., Cao R., Svensson K., Bertilsson G., Asman M., Tanaka H., Cao Y., Berkenstam A., Poellinger L. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001, 414:550-554.
17. Yamashita T., Ohneda O., Nagano M., Iemitsu M., Makino Y., Tanaka H., Miyauchi T., Goto K., Ohneda K., Fujii-Kuriyama Y., Poellinger L., Yamamoto M. Abnormal heart development and lung remodeling in mice lacking the hypoxia-inducible factor-related basic helix-loop-helix PAS protein NEPAS. Mol. Cell. Biol. 2008, 28:1285-1297.
18. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 2002, 8:S62-S67.
19. Brahimi-Horn M.C., Chiche J., Pouyssegur J. Hypoxia and cancer. J. Mol. Med. 2007, 85:1301-1307.
20. Carroll V.A., Ashcroft M. Targeting the molecular basis for tumour hypoxia. Expert Rev. Mol. Med. 2005, 7:1-16.
21. Semenza G.L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010, 29:625-634.
22. LaVan F.B., Hunt T.K. Oxygen and wound healing. Clin. Plast. Surg. 1990, 17:463-472.
23. Tandara A.A., Mustoe T.A. Oxygen in wound healing-more than a nutrient. World J. Surg. 2004, 28:294-300.
24. Detmar M. Tumor angiogenesis. J. Investig. Dermatol. Symp. Proc. 2000, 5:20-23.
25. Elson D.A., Ryan H.E., Snow J.W., Johnson R., Arbeit J.M. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res. 2000, 60:6189-6195.
26. Rosenberger C., Solovan C., Rosenberger A.D., Jinping L., Treudler R., Frei U., Eckardt K.U., Brown L.F. Upregulation of hypoxia-inducible factors in normal and psoriatic skin. J. Investig. Dermatol. 2007, 127:2445-2452.
27. Heidenreich R., Rocken M., Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int. J. Exp. Pathol. 2009, 90:232-248.
28. Evans S.M., Schrlau A.E., Chalian A.A., Zhang P., Koch C.J. Oxygen levels in normal and previously irradiated human skin as assessed by EF5 binding. J. Investig. Dermatol. 2006, 126:2596-2606.
29. Takagi S., Tojo H., Tomita S., Sano S., Itami S., Hara M., Inoue S., Horie K., Kondoh G., Hosokawa K., Gonzalez F.J., Takeda J. Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function. J. Clin. Invest. 2003, 112:1372-1382.
30. Geng S., Mezentsev A., Kalachikov S., Raith K., Roop D.R., Panteleyev A.A. Targeted ablation of Arnt in mouse epidermis results in profound defects in desquamation and epidermal barrier function. J. Cell Sci. 2006, 119:4901-4912.
31. Boutin A.T., Weidemann A., Fu Z., Mesropian L., Gradin K., Jamora C., Wiesener M., Eckardt K.U., Koch C.J., Ellies L.G., Haddad G., Haase V.H., Simon M.C., Poellinger L., Powell F.L., Johnson R.S. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 2008, 133:223-234.
32. Dickson M.A., Hahn W.C., Ino Y., Ronfard V., Wu J.Y., Weinberg R.A., Louis D.N., Li F.P., Rheinwald J.G. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 2000, 20:1436-1447.
33. Bernaudin M., Nedelec A.S., Divoux D., MacKenzie E.T., Petit E., Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 2002, 22:393-403.
34. Scortegagna M., Martin R.J., Kladney R.D., Neumann R.G., Arbeit J.M. Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res. 2009, 69:2638-2646.
35. Fandrey J. Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R977-R988.
36. Ward M.E., Toporsian M., Scott J.A., Teoh H., Govindaraju V., Quan A., Wener A.D., Wang G., Bevan S.C., Newton D.C., Marsden P.A. Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant. J. Clin. Invest. 2005, 115:3128-3139.
37. Ngo M.A., Sinitsyna N.N., Qin Q., Rice R.H. Oxygen-dependent differentiation of human keratinocytes. J. Investig. Dermatol. 2007, 127:354-361.
38. Kuwahira I., Gonzalez N.C., Heisler N., Piiper J. Changes in regional blood flow distribution and oxygen supply during hypoxia in conscious rats. J. Appl. Physiol. 1993, 74:211-214.
39. Bedogni B., Powell M.B. Hypoxia, melanocytes and melanoma-survival and tumor development in the permissive microenvironment of the skin. Pigment Cell Melanoma Res. 2009, 22:166-174.
40. Giatromanolaki A., Harris A.L. Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res. 2001, 21:4317-4324.
41. Huffman J.L., Mokashi A., Bachinger H.P., Brennan R.G. The basic helix-loop-helix domain of the aryl hydrocarbon receptor nuclear transporter (ARNT) can oligomerize and bind E-box DNA specifically. J. Biol. Chem. 2001, 276:40537-40544.
42. Peyssonnaux C., Boutin A.T., Zinkernagel A.S., Datta V., Nizet V., Johnson R.S. Critical role of HIF-1alpha in keratinocyte defense against bacterial infection. J. Invest. Dermatol. 2008, 128:1964-1968.
43. Ashurst J.L., Chen C.K., Gilbert J.G., Jekosch K., Keenan S., Meidl P., Searle S.M., Stalker J., Storey R., Trevanion S., Wilming L., Hubbard T. The Vertebrate Genome Annotation (Vega) database. Nucleic Acids Res. 2005, 33:D459-D465.
44. Luo G., Gu Y.Z., Jain S., Chan W.K., Carr K.M., Hogenesch J.B., Bradfield C.A. Molecular characterization of the murine Hif-1 alpha locus. Gene Expr. 1997, 6:287-299.
45. Wenger R.H., Rolfs A., Marti H.H., Guenet J.L., Gassmann M. Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor-1 alpha. Biochem. Biophys. Res. Commun. 1996, 223:54-59.
46. Marti H.H., Katschinski D.M., Wagner K.F., Schaffer L., Stier B., Wenger R.H. Isoform-specific expression of hypoxia-inducible factor-1alpha during the late stages of mouse spermiogenesis. Mol. Endocrinol. 2002, 16:234-243.
47. Li H., Ko H.P., Whitlock J.P. Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1alpha. J. Biol. Chem. 1996, 271:21262-21267.
48. Gradin K., McGuire J., Wenger R.H., Kvietikova I., Fhitelaw M.L., Toftgard R., Tora L., Gassmann M., Poellinger L. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 1996, 16:5221-5231.
49. Wenger R.H., Camenisch G., Desbaillets I., Chilov D., Gassmann M. Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction. Cancer Res. 1998, 58:5678-5680.
50. Yang E., van Nimwegen E., Zavolan M., Rajewsky N., Schroeder M., Magnasco M., Darnell J.E. Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes. Genome Res. 2003, 13:1863-1872.
51. Garneau N.L., Wilusz J., Wilusz C.J. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 2007, 8:113-126.
52. Azad M.B., Chen Y., Henson E.S., Cizeau J., McMillan-Ward E., Israels S.J., Gibson S.B. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 2008, 4:195-204.
53. Ginouves A., Ilc K., Macias N., Pouyssegur J., Berra E. PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis. Proc. Natl Acad. Sci. USA 2008, 105:4745-4750.
54. Chavez J.C., Baranova O., Lin J., Pichiule P. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J. Neurosci. 2006, 26:9471-9481.
55. Patel S.A., Simon M.C. Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ. 2008, 15:628-634.
56. Bodo E., Kromminga A., Funk W., Laugsch M., Duske U., Jelkmann W., Paus R. Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin. FASEB J. 2007, 21:3346-3354.
57. Scheidemann F., Therrien J.P., Vogel J., Pfutzner W. In vivo synthesis and secretion of erythropoietin by genetically modified primary human keratinocytes grafted onto immunocompromised mice. Exp. Dermatol. 2010, 19:289-297.
58. Acs G., Zhang P.J., McGrath C.M., Acs P., McBroom J., Mohyeldin A., Liu S., Lu H., Verma A. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am. J. Pathol. 2003, 162:1789-1806.
59. Maynard M.A., Qi H., Chung J., Lee E.H., Kondo Y., Hara S., Conaway R.C., Conaway J.W., Ohh M. Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J. Biol. Chem. 2003, 278:11032-11040.
60. Hirsila M., Koivunen P., Gunzler V., Kivirikko K.I., Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 2003, 278:30772-30780.
61. Gu Y.Z., Moran S.M., Hogenesch J.B., Wartman L., Bradfield C.A. Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α. Gene Expr. 1998, 7:205-213.
62. Makino Y., Kanopka A., Wilson W.J., Tanaka H., Poellinger L. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J. Biol. Chem. 2002, 277:32405-32408.
63. Makino Y., Uenishi R., Okamoto K., Isoe T., Hosono O., Tanaka H., Kanopka A., Poellinger L., Haneda M., Morimoto C. Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells. J. Biol. Chem. 2007, 282:14073-14082.
64. 2 tension. Proc. Natl Acad. Sci. USA 1995, 92:5510-5514.
65. Ismailova A.Z., Makeshova A.B., Eralieva M.O., Levina A.A., Mamukova J.I., Raimzhanov A.R. Regulation of erythropoiesis in patients with suppressed hematopoiesis during mountain climatic treatment. Ter. Arkh. 2010, 82:39-42.